Friulimicin D

O=C([C@H]([C@H](NC(C(CCC1)([H])N1C([C@@H](NC([C@@](NC2=O)([H])[C@H](N)C)=O)C(C)C)=O)=O)C)NC([C@H](CC(N)=O)NC(C/C=C\CCCCCCCC(C)CC)=O)=O)N(CCCC3)[C@@]3([H])C(N[C@@](C(N[C@H](C(NCC(N[C@H](C(NC2)=O)CC(O)=O)=O)=O)CC(O)=O)=O)([H])[C@H](C)C(O)=O)=O

[1]C Müller, et al. Sequencing and analysis of the biosynthetic gene cluster of the lipopeptide antibiotic Friulimicin in Actinoplanes friuliensis. Antimicrob Agents Chemother. 2007 Mar;51 (3) :1028-37.|[2]T Schneider, et al. The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother. 2009 Apr;53 (4) :1610-8.